UmanDiagnostics and Quanterix improving brain injury diagnostics

(2016-11-21) UmanDiagnostics has today entered into a strategic partnership with Quanterix™, a Boston based company digitizing biomarker analysis for precision health. The aim is to further develop UmanDiagnostics NF-light® ELISA to enable blood analysis of traumatic brain injuries and neurodegenerative diseases. Combining superior antibodies with the most sensitive technology has the possibility to transform neurological diagnostics.

UmanDiagnostics starts selling reagents

(2016-10-07) Due to the great interest in using our antibodies on ultra sensitive platforms we are very happy to announce that we now will be able to deliver antibodies and antigen for Neurofilament light detection. Please use our contact form if you need more information.

UmanDiagnostics nominated for award

(2016-09-20) UmanDiagnostics has been nominated as the “spin-ofcompany
of the year”
 at the yearly business awards Umeågalan 2016.